Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

N27 What people want! Exploring inflammatory bowel disease patients’ perspectives on healthcare professionals addressing sexual well-being

ECCO'20 Vienna

Year: 2020
Authors:

S. Fourie1, W. Czuber-Dochan2, C. Norton2

1University of Oxford, WIMM, Oxford, UK, 2King’s College London, Florence Nightingale Faculty of Nursing- Midwifery and Palliative Care, London, UK

N28 Effectiveness of pre-biologic screening for viral hepatitis and HIV

ECCO'20 Vienna

Year: 2020
Authors:

M. Clarke, J. Goodhand, T. Ahmad, V. Cairnes, N.A. Kennedy

Royal Devon & Exeter NHS Foundation Trust, Gastroenterology, Exeter, UK

N29 Application of the AREA model to a standard care plan for patients with inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

M.I. Mateos Hernandez

Salamanca Hospital, Digestive system, Salamanca, Spain

N30 Experience of living with intestinal failure: a systematic review of qualitative studies

ECCO'20 Vienna

Year: 2020
Authors:

W. Czuber-Dochan, Q. Liu, D. Roberts, P. Smith, C. Norton

King’s College London, Florence Nightingale Faculty of Nursing- Midwifery & Palliative Care, London, UK

N31 What factors affect quality of life and psychological well-being in patients with intestinal failure? A systematic review of quantitative studies

ECCO'20 Vienna

Year: 2020
Authors:

D. Roberts1, Q. Liu1, W. Czuber-Dochan1, P. Smith2, C. Norton1

1King’s College London, Adult Nursing, London, UK, 2Gastroenterology, Royal Liverpool University Hospitals Trust, Liverpool, UK

OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study

ECCO'20 Vienna

Year: 2020
Authors:

J.F. Colombel1, J. Panés2, G. D’Haens3, S. Schreiber4, R. Panaccione5, L. Peyrin-Biroulet6, E.V. Loftus Jr7, S. Danese8, E. Louis9, A. Armuzzi10, M. Ferrante11, H. Vogelsang12, J. Lefebvre13, T. Doan14, W. Xie15, B. Huang15, J. Petersson16, J. Kalabic17, A. Robinson18, W.J. Sandborn19

1Department of Gastroenterology, Icahn School of Medicine at Mt Sinai, New York, NY, USA, 2Department of Gastroenterology, Hospital Clinic Barcelona- IDIBAPS- CIBERehd, Barcelona, Spain, 3Department of Inflammatory Bowel Disease, Amsterdam, Amsterdam University Medical Centers, The Netherlands, 4Department of Internal Medicine, University Hospital Schleswig-Holstein, Kiel, Germany, 5Department of Medicine, University of Calgary, Calgary, Canada, 6Department of Gastroenterology, University Hospital of Nancy - Lorraine University, Vandoeuvre, France, 7Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA, 8Department of Gastroenterology, Istituto Clinico Humanitas, Rozzano- Milan, Italy, 9Department of Gastroenterology, University Hospital CHU of Liège, Liège, Belgium, 10Department of Gastroenterology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, 11Department of Gastroenterology, University Hospitals Leuven - KU Leuven, Leuven, Belgium, 12Department of Gastroenterology, Medical University of Vienna, Vienna, Austria, 13Department of Clinical Studies, AbbVie Inc., North Chicago, IL, USA, 14Department of Pharmacovigillance, AbbVie Inc., North Chicago, IL, USA, 15Department of Statistics, AbbVie Inc., North Chicago, IL, USA, 16Department of Gastroenterology, AbbVie Inc., North Chicago, IL, USA, 17Department of Immunology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany, 18Department of Immunology, AbbVie Inc., North Chicago, IL, USA, 19Department of Gastroenterology, University of California at San Diego, La Jolla, CA, USA

OP02 Impact of therapeutic strategies on intestinal resection rate in paediatric inflammatory bowel diseases: A population-based cohort study over a 24-year period (1988–2011)

ECCO'20 Vienna

Year: 2020
Authors:

D. Ley1, A. Leroyer2, C. Dupont3, H. Sarter2, V. Bertrand4, C. Spyckerelle5, N. Guillon2, B. Pariente6, G. Savoye7, D. Turck1, C. Gower-Rousseau2, M. Fumery8, Epimad group

1Paediatric Gastroenterology Unit, Lille University Hospital and Lille University, Lille, France, 2Epidemiology and Public Health, Lille University Hospital and Lille University, Lille, France, 3Paediatric Unit, Caen University Hospital, Caen, France, 4Paediatric Unit, Havre Hospital, Havre, France, 5Paediatric Unit, Saint Vincent Hospital, Lille, France, 6Gastroenterology Unit, Lille University Hospital and Lille University, Lille, France, 7Gastroenterology Unit, Rouen University Hospital and Rouen University, Rouen, France, 8Gastroenterology Unit, Amiens University Hospital and Amiens University, Amiens, France

OP03 Reduced need for surgery and medical therapy after early ileocaecal resection for Crohn’s disease: Long-term follow-up of the LIR!C trial

ECCO'20 Vienna

Year: 2020
Authors:

T. Stevens MD1, L. Haasnoot1, G. D’Haens1, C. Buskens2, E.J. de Groof2, E. Eshuis1, T. Gardenbroef3, B. Mol1, P. Stokkers3, W. Bemelman2, C. Ponsioen1, LIR!C

1Department of Gastroenterology and Hepatology, Amsterdam UMC- location AMC, Amsterdam, The Netherlands, 2Department of Surgery, Amsterdam UMC- location AMC, Amsterdam, The Netherlands, 3Department of Gastroenterology and Hepatology, OLVG, Amsterdam, The Netherlands

OP04 Long-term outcomes after ileocolonic resection in Crohn’s disease according to the severity of early endoscopic recurrence

ECCO'20 Vienna

Year: 2020
Authors:

N. Hammoudi1, C. Auzolle1, M.L. Tran Minh1, G. Boschetti2, M. Bezault3, A. Buisson4, B. Pariente5, X. Treton6, P. Seksik7, M. Fumery8, L. Le Bourhis9, S. Nancey2, M. Allez1, REMIND Study Group

1Department of Gastroenterology, APHP Saint Louis, Paris, France, 2Department of Gastroenterology, Hospices Civils de Lyon, Lyon, France, 3REMIND, Group, Paris, France, 4Department of Gastroenterology, CHU Clermont-Ferrand, Clermont-Ferrand, France, 5Department of Gastroenterology, Hôpital Claude Huriez, Lille, France, 6Department of Gastroenterology, APHP Hôpital Beaujon, Clichy, France, 7Department of Gastroenterology, APHP Hôpital Saint-Antoine, Paris, France, 8Department of Gastroenterology, CHU Amiens, Amiens, France, 9INSERM, Unité 1160, Paris, France

OP05 Validation of the Lémann index in Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

B. Pariente1, J. Torres2, J. Burisch3, N. Arebi4, B. Barberio5, D. Duricova6, P. Ellul7, A. Goldis8, I. Kaimakliotis9, K. Katsanos10, Z. Krznaric11, D. Mc Namara12, N. Pedersen13, S. Sebastian14, P. Weimars15, P. Lung16, C. Lacognata17, M. Horak18, V. Domislovic11, I. Murphy12, R. Ungaro19, J.F. Colombel19, J.Y. Mary20

1Gastroenterology Department, CHRU Lille, Lille, France, 2Department of Gastroenterology, Hospital Beatriz Ângelo, Lisbona, Portugal, 3Department of Gastreonterology, Nordsjællands Hospital, Copenhagen, Denmark, 4Department of Gastroenterology, St. Marks Academic Institute, London, UK, 5Department of Gastroenterology, University of Padua, Padua, Italy, 6Department of Gastroenterology, Charles University, Prague, Czech Republic, 7Department of Gastroenterology, Brown Block Mater Dei, Msida, Malta, 8Department of Gastroenterology, Universitu of Timisoara, Timisoara, Romania, 9Department of Gastroenterology, Nicosia Private Practice, Nicosia, Cyprus, 10Department of Gastroenterology, Ioannina, Greece, 11Department of Gastroenterology, Zagreb, Croatia, 12Department of Gastroenterology, Dublin, Ireland, 13Department of Gastroenterology, Slagelse, Denmark, 14Department of Gastroenterology, Hull, London, UK, 15Department of Gastroenterology, Copenhagen, Denmark, 16Department of Gastroenterology, London, UK, 17Department of Gastroenterology, Padova, Italy, 18Department of Gastroenterology, Prague, Czech Republic, 19Department of Gastroenterology, Mount Sinai, New York, USA, 20Department of Gastroenterology, Saint Louis Hospital, Paris, France

OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis

ECCO'20 Vienna

Year: 2020
Authors:

Y. Haberman Ziv1, N. Loberman-Nachum1, S. Katya1, A. Di Segni1, G. Efroni1, T. Braun1, M. BenShoshan1, D. Shouval1, L.A. Denson2, A. Amir1, R. Unger3, B. Weiss1, CCF funded RISK Crohn Disease study

1Department of Pediatric Gastroenterology, Tel-HaShomer Sheba Medical Center, Ramat Gan, Israel, 2Department of Gastroenterology, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA, 3Mina and Everard Goodman Faculty of Life Science, Bar-Ilan University, Ramat Gan, Israel

OP07 The epidemiology of inflammatory bowel diseases among immigrants to Denmark: A population-based cohort study

ECCO'20 Vienna

Year: 2020
Authors:

M. Agrawal1, S. Shrestha2, G. Corn3, N.M. Nielsen3, M. Frisch3, J.F. Colombel1, T. Jess3

1The Dr Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA, 2School of Medical Sciences, Orebro University, Orebro, Sweden, 3Department of Epidemiology Research, Statens Serum Institute, Copenhagen, Denmark

OP08 Inflammatory bowel disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and Sweden

ECCO'20 Vienna

Year: 2020
Authors:

J. Axelrad1, O. Olen2, M. Sachs2, R. Erichsen3, L. Pedersen3, J. Halfvarson4, J. Askling2, A. Ekbom2, H.T. Sørensen3, J. Ludvigsson5

1Department of Gastroenterology, New York University School of Medicine, New York, NY, USA, 2Department of Medicine, Karolinska Institute, Stockholm, Sweden, 3Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark, 4Department of Gastroenterology, Örebro University, Örebro, Sweden, 5Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden

OP09 Immunomodulatory mechanisms of faecal microbiota transplantation are associated with clinical response in ulcerative colitis: early results from STOP-Colitis

ECCO'20 Vienna

Year: 2020
Authors:

M.N. Quraishi1,2, Y.H. Oo3, A. Beggs4, D. Withers3, A. Acharjee4,5, N. Sharma1,2, S. Manzoor1, A.L. Hart6, D.R. Gaya7, N.J. Loman8, P.M. Hawkey1, K. Gerasimidis9, R. Hansen10, G. Gkoutous4,5,11, T.H. Iqbal1,2

1University of Birmingham Microbiome Treatment Centre, University of Birmingham, Birmingham, UK, 2Department of Gastroenterology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK, 3Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK, 4Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK, 5NIHR Surgical Reconstruction and Microbiology Research Centre, University of Birmingham, Birmingham, UK, 6IBD Unit, St Marks Hospital, London, UK, 7Gastroenterology Unit, Glasgow Royal Infirmary, Glasgow, UK, 8Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK, 9Human Nutrition- School of Medicine- Dentistry and Nursing, University of Glasgow, Glasgow, UK, 10Department of Paediatric Gastroenterology, Royal Hospital for Children Glasgow, Glasgow, UK, 11MRC, Health Data Research UK, Birmingham, UK

OP10 IgA coating of intestinal microbiota is associated with inflammatory bowel disease in twin pairs discordant for inflammatory bowel disease

ECCO'20 Vienna

Year: 2020
Authors:

E. Brand1, Y. Laenen2, F. van Wijk3, M. de Zoete4, B. Oldenburg5, On behalf of the Dutch TWIN-IBD Consortium

1Department of Gastroenterology and Hepatology, Centre for Translational Immunology, University Medical Centre - Utrecht, Utrecht, The Netherlands, 2Department of Infectious Diseases and Immunology, Utrecht University, Utrecht, The Netherlands, 3Centre for Translational Immunology, University Medical Centre Utrecht, Utrecht, The Netherlands, 4Department of Medical Microbiology, University Medical Centre Utrecht, Utrecht, The Netherlands, 5Department of Gastroenterology and Hepatology, University Medical Centre - Utrecht, Utrecht, The Netherlands

OP11 Exposure to an inflammatory mix re-induces inflammation in organoids of ulcerative colitis patients, independent of the inflammatory state of the tissue of origin

ECCO'20 Vienna

Year: 2020
Authors:

K. Arnauts1,2, B. Verstockt1,3, J. Sabino1,3, S. Vermeire1,3, C. Verfaillie2, M. Ferrante1,3

1Department of Chronic Diseases, Metabolism and Ageing, KU Leuven, TARGID, Leuven, Belgium, 2Department of Development and Regeneration, Stem Cell Institute Leuven, KU Leuven, Leuven, Belgium, 3Department of Gastroenterology and Hepatology, KU Leuven, University Hospitals - Leuven, Leuven, Belgium

OP12 The incidence and disease course of perianal Crohn’s disease: A Danish nationwide cohort study

ECCO'20 Vienna

Year: 2020
Authors:

M.D. Wewer1, M. Zhao2, A. Nordholm-Carstensen3, J.B. Seidelin1, J. Burisch2

1Department of Gastroenterology, Herlev Gentofte University Hospital, Herlev, Denmark, 2Gastrounit- Medical Division, Amager Hvidovre University Hospital, Hvidovre, Denmark, 3Digestive Disease Center, Bispebjerg Hospital, Copenhagen, Denmark

OP13 Glyco-fingerprint as a relevant risk factor on colitis-associated cancer

ECCO'20 Vienna

Year: 2020
Authors:

A. Dias1, E. Gomes1, M. Silva1, Â. Fernandes1, M. Garrido2, R. Marcos-Pinto2, P. Lago2, S. Pinho1

1i3S – Institute for Research and Innovation in Health, University of Porto, Immunology- Cancer and Glycomedicine Group, Porto, Portugal, 2Department of Gastroenterology, Porto Centre Hospital, Porto, Portugal

OP14 Risk of colorectal cancer diagnosis and colorectal cancer mortality in Crohn’s disease: A Scandinavian population-based cohort study

ECCO'20 Vienna

Year: 2020
Authors:

O. Olen1, R. Erichsen2, M.C. Sachs1, L. Pedersen2, J. Halfvarson3, J. Askling1, A. Ekbom1, H.T. Sørensen2, J.F. Ludvigsson4

1Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden, 2Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark, 3Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden, 4Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

OP15 Multi-omic data integration with network analysis reveals underlying molecular mechanisms driving Crohn’s disease heterogeneity

ECCO'20 Vienna

Year: 2020
Authors:

P. Sudhakar1,2,3, B. Verstockt1,4, J. Cremer5, S. Verstockt1, T. Korcsmaros2,3, M. Ferrante1,4, S. Vermeire1,4

1Department of Chronic Diseases, Metabolism and Ageing - TARGID, KU Leuven, Leuven, Belgium, 2Gut Microbes and Health, Quadram Institute, Norwich, UK, 3Korcsmaros Group, Organisms and Ecosystems, Earlham Institute, Norwich, UK, 4Department of Gastroenterology and Hepatology, KU Leuven, University Hospitals Leuven, Leuven, Belgium, 5Laboratory of Clinical Immunology, Department of Microbiology and Immunology, KU Leuven, Leuven, Belgium